Found 245 matching trials
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT PHASE2 Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Show More Location
Hospital Universitario Son Espases
Learn More & Join Trial
AZA Combined with R-GemOx for Elderly DLBCL Patients PHASE2 This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Show More Location
Daping Hospital, Third Military Medical University (Army Medical University)
Learn More & Join Trial
Pancreatic Adenocarcinoma Signature Stratification for Treatment PHASE2 This is a randomized multicentre phase II trial with a large translational ...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse PHASE1 The purpose of this study is to determine the recommended dose of CMC544 ad...
Show More Learn More & Join Trial
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage PHASE3 Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer PHASE2 This study is comparing two combinations of chemotherapy treatments in pati...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma N/A Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Show More Location
Zhejiang Province Cancer Hospital
Learn More & Join Trial